S
GTHX

SignatureFD’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

SignatureFD’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-910
Closed -$2.78K – 3273
2023
Q4 		$2.78K Sell
910
-43,577
-98% -$81.9K ﹤0.01% 2676
2023
Q3 		$64.1K Hold
44,487
– – ﹤0.01% 1272
2023
Q2 		$111K Hold
44,487
– – ﹤0.01% 1005
2023
Q1 		$119K Sell
44,487
-65
-0.1% -$312 ﹤0.01% 952
2022
Q4 		$242K Sell
44,552
-105
-0.2% -$880 0.01% 642
2022
Q3 		$558K Buy
44,657
+170
+0.4% +$1.94K 0.02% 338
2022
Q2 		$220K Buy
44,487
+12,000
+37% +$66.5K 0.01% 665
2022
Q1 		$247K Hold
32,487
– – 0.01% 651
2021
Q4 		$332K Hold
32,487
– – 0.01% 535
2021
Q3 		$436K Hold
32,487
– – 0.02% 417
2021
Q2 		$713K Buy
32,487
+11,545
+55% +$256K 0.03% 260
2021
Q1 		$504K Hold
20,942
– – 0.02% 312
2020
Q4 		$377K Sell
20,942
-8,500
-29% -$127K 0.02% 337
2020
Q3 		$340K Hold
29,442
– – 0.02% 332
2020
Q2 		$714K Hold
29,442
– – 0.04% 158
2020
Q1 		$324K Buy
29,442
+8,500
+41% +$159K 0.03% 267
2019
Q4 		$553K Sell
20,942
-17,000
-45% -$398K 0.04% 223
2019
Q3 		$864K Hold
37,942
– – 0.07% 114
2019
Q2 		$1.16M Hold
37,942
– – 0.1% 80
2019
Q1 		$630K Hold
37,942
– – 0.05% 143
2018
Q4 		$727K Buy
37,942
+17,000
+81% +$637K 0.07% 119
2018
Q3 		$1.09M Buy
20,942
+5,780
+38% +$315K 0.11% 85
2018
Q2 		$659K Buy
+15,162
New +$650K 0.07% 132

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SignatureFD's GTHX Position: Q1 2024 in Review

SignatureFD sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 910 shares — an estimated $2.78K sold.

SignatureFD first reported a position in GTHX in Q2 2018 and held it in 23 quarters. The position peaked at $1.16M in Q2 2019. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

  • SignatureFD reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • SignatureFD sold 910 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.78K.
  • SignatureFD first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 23 quarters.
  • SignatureFD's G1 Therapeutics, Inc. Common Stock position peaked at $1.16M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.